Tecartus 200000000 Cells (Brexucabtagene Autoleucel SUSPENSION) 200000000 CELLS

TECARTUS (brexucabtagene autoleucel) is a specialized suspension for intravenous use, containing 200,000,000 cells. This advanced therapy is designed to target certain types of cancer cells, offering a novel approach to treatment.

Strength

200000000 CELLS

Manufacturer / TM Owner

GILEAD SCIENCES CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TECARTUS is a type of cellular therapy used in the treatment of specific cancers. It works by using the body's own immune cells to target and attack cancer cells. This therapy is typically considered when other treatments have not been effective or are no longer an option. The primary use of TECARTUS is in the management of certain types of cancer, providing a targeted approach to treatment.

Side Effects

TECARTUS may cause various effects, including fatigue, fever, and chills. Some individuals may experience more severe reactions, such as cytokine release syndrome or neurological events. It is important to monitor for any unusual symptoms and consult with a healthcare provider.

Precautions & Warnings

TECARTUS should be handled with care and administered under the supervision of a healthcare professional. It is crucial to follow all safety guidelines and precautions provided by the manufacturer. Patients should be monitored closely for any adverse reactions or side effects.

Avoid Interactions

TECARTUS may interact with other medications or treatments. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Certain medications may affect the effectiveness or safety of TECARTUS.

Frequently Asked Questions

TECARTUS is used in the treatment of specific types of cancer, offering a targeted approach by using the body's immune cells.

TECARTUS is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include fatigue, fever, and chills. More severe reactions, such as cytokine release syndrome, may also occur.

TECARTUS may interact with other medications, so it is important to consult with a healthcare provider before combining treatments.

TECARTUS should be handled with care and administered under the supervision of a healthcare professional, with close monitoring for any adverse reactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.